newsfilter
← Latest News
GlobeNewswire·

Brickell Biotech Announces $5.0 Million Bought Deal Offering of Common Stock

BOULDER, Colo., July 19, 2021 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (NASDAQ:BBI) ("Brickell" or the "Company"), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment